80 research outputs found
Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: A multicentre, randomized controlled trial
Abstract. Background: Due to prophylactic colectomy, mortality in patients with familial adenomatous polyposis (FAP) has changed, with duodenal cancer currently being the main cause of death. Although celecoxib reduces duodenal polyp density in patients with FAP, its long-term use may increase the risk of cardiovas
Interdisciplinary European guidelines on surgery of severe obesity
W 2005 roku, dzięki wspólnemu wysiłkowi głównych europejskich
towarzystw naukowych aktywnych na polu leczenia otyłości został
powołany zespół ekspertów nazwany Bariatryczno-Naukową
Grupą Badawczą (BSCG). Towarzystwami, które stworzyły ten
zespół i oddelegowały swoich przedstawicieli do prac w opracowaniu
wytycznych były: Międzynarodowe Towarzystwo Chirurgicznego
Leczenia Otyłości (IFSO), Oddział Europejski Międzynarodowego
Towarzystwa Chirurgicznego Leczenia Otyłości
(IFSO-EC), Europejskie Towarzystwo Badań nad Otyłością
(EASO), Europejska Grupa ds. Otyłości u Dzieci (ECOG) (razem
z Międzynarodową Grupą Zwalczania Otyłości). Bariatryczno-Naukowa
Grupa Badawcza składała się z władz reprezentujących
powyższe towarzystwa (czterech czynnych przewodniczących,
dwóch byłych, jeden honorowy, dwóch dyrektorów wykonawczych),
a także najwybitniejszych ekspertów w tej dziedzinie. Skład BSCG pozwolił na całościowe objęcie zagadnienia leczenia
otyłości olbrzymiej z uwzględnieniem różnorodności geograficznej
i etnicznej Europy. Członkowie BSCG odbyli wiele spotkań
poświęconych stworzeniu wytycznych, które odzwierciedlałyby
współczesną wiedzę i doświadczenie w zakresie leczenia
otyłości olbrzymiej.In 2005, for the first time in European history, an extraordinary expert
panel named BSCG (Bariatric Scientific Collaborative Group),
was appointed through joint effort of the major European scientific
societies which are active in the field of obesity management. Societies
that constituted this panel were: IFSO - International Federation
for the Surgery of Obesity, IFSO-EC - International Federation
for the Surgery of Obesity - European Chapter, EASO - European Association for Study of Obesity, ECOG - European
Childhood Obesity Group, together with the IOTF (International
Obesity Task Force) which was represented during the completion
process by its representative. The BSCG was composed not
only of the top officers representing the respective scientific societies
(four acting presidents, two past presidents, one honorary president,
two executive directors), but was balanced with the presence
of many other key opinion leaders in the field of obesity. The
BSCG composition allowed the coverage of key disciplines in comprehensive
obesity management, as well as reflecting European
geographical and ethnic diversity. This joint BSCG expert panel
convened several meetings which were entirely focused on guidelines
creation, during the past 2 years. There was a specific effort
to develop clinical guidelines, which will reflect current knowledge,
expertise and evidence based data on morbid obesity treatment
Management of obesity in adults: European clinical practice guidelines
Stworzenie jednolitych wytycznych postępowania w otyłości jest
złożone. Obejmują one zarówno zalecenia diagnostyczne, lecznicze,
jak i działania w zakresie prewencji. Wobec wielu publikacji
i różnic poglądów oraz świadomości krótkotrwałości efektu odchudzającego
u poszczególnych osób wielu uważa, że trudno jest
ustalić właściwe postępowanie w otyłości. Różnorodność zasad
postępowania w kraju oraz pomiędzy regionami Europy utrudnia
ustalenie i wprowadzenie standardów. W ustalaniu obecnych wytycznych
za podstawę brano wiedzę opartą na dowodach (EBM), a w razie wątpliwości uzupełniano na podstawie doświadczenia
klinicznego i różnorodności regionalnej oraz uzgodnionego stanowiska
zespołu.
W podsumowaniu stwierdzono, że: 1) lekarz jest odpowiedzialny
za rozpoznanie otyłości jako choroby oraz pomoc w odpowiedniej
prewencji i leczeniu; 2) leczenie powinno być oparte na dobrej
praktyce klinicznej i EBM; 3) leczenie otyłości powinno wyznaczać
indywidualne realne cele i dożywotnie postępowanie.The development of consensus guidelines for obesity is complex. It
involves recommending both treatment interventions and interventions
related to screening and prevention. With so many publications
and claims, and with the awareness that success for the individual
is short-lived, many find it difficult to know what action is appropriate
in the management of obesity. Furthermore, the significant
variation in existing service provision both within countries as well
as across the regions of Europe makes a standardised approach,
even if evidence-based, difficult to implement. In formulating these
guidelines, we have attempted to use an evidence based approach
while allowing flexibility for the practicing clinician in domains where
evidence is currently lacking and ensuring that in treatment there
is recognition of clinical judgment and of regional diversity as well
as the necessity of an agreed approach by the individual and family.
We conclude that 1) physicians have a responsibility to recognise
obesity as a disease and help obese patients with appropriate
prevention and treatment, 2) treatment should be based on good
clinical care and evidence- based interventions and 3) obesity treatment
should focus on realistic goals and lifelong management
VIDEO TRACKING USING ACOUSTIC TRIANGULATION
This study focuses on the detection and triangulation of sound sources. Specifically, we focus on the detection of sound in order to track a person’s position with a video camera. Acoustic tracking, an alternative to visual tracking, is relatively inexpensive, passive (does not emit energy), and effective in low lighting environments [3]. Our project is broken into two major aspects: accurately discerning input as opposed to background noise and the localization of the sound source. In order to focus on the input signal, we analyze two methods: time averaging and impulse culling. After the sound is analyzed and filtered we focus on the triangulation of the source in 2-D space using direct and estimation techniques requiring three microphones. This process is geared towards finding a compromise between performance and complexity which allows implementation on a standard micro-controller
Progression of duodenal adenomatosis in familial adenomatous polyposis: due to ageing of subjects and advances in technology
Familial adenomatous polyposis patients are at risk of duodenal cancer. Surveillance is indicated and the extent of duodenal polyposis is quantified by the Spigelman staging system. We noticed an impressive increase in high Spigelman stages over the years and therefore decided to investigate whether this increase might be due to the time-lapse since the inception of surveillance or related to improvements in endoscopic imaging and/or changes in dysplasia-reporting. Patients who were investigated by the same endoscopist since 1980 in at least 2 different episodes of technical improvements were eligible. The period 1980–2009 was divided into 4 episodes using the following landmarks: replacement of fibre-endoscopes by video-endoscopes in 1987, change in processors in 1995, change in image resolution in 2000, and change in dysplasia-reporting in 2006. An increase in Spigelman stages from low stages (0–II 100%) to high stages (III 28.1%, IV 43.8%) was seen (median follow-up: 19.5 years). In patients who progressed, a median of 4 years elapsed before progression by one stage occurred and 7 years to progress by two stages. In a mixed-model analysis, both time-lapse and technical improvements were determinant factors for duodenal disease progression. When both factors were introduced in the model, the time-lapse as well as the change in image resolution and dysplasia-ranking contributed consistently in increasing Spigelman scores and stages. The impressive increase in severity of duodenal polyposis is determined by time-lapse, technological advances and change in dysplasia-reporting. These results might call for a revised Spigelman classification
Old age, malnutrition, and pressure sores: an ill-fated alliance
Wound healing is a complex, tightly regulated process, consisting of three distinct phases. In each phase of wound healing, energy and macronutrients are required. Moreover, animal studies have established a specific role for certain nutrients such as the amino acid arginine, the vitamins A, B, and C, and the elements selenium, manganese, zinc, and copper. Chronic wounds such as pressure ulcers have extensively been investigated as to the risk of development, prevention, and cure. Here, the combination of old age, malnutrition, and pressure ulcers is highly unfortunate. Energy and nutrients, such as proteins and vitamins B and C, being deficient at old age are needed in pressure ulcer healing. Malnutrition is associated with skin anergy and with immobility because of mental apathy and muscle wasting. Severe malnutrition, impaired oral intake, and the risk of pressure ulcer formation appear to be interrelated. Adequate nutrition may reverse the underfed state unless an underlying wasting disease was present and appeared to reduce the prevalence and incidence in cross-sectional and prospective observational studies. However, attempts to prevent pressure ulcers by nutritional intervention were divergent in outcome, reflecting the difficulties to meet the daily requirements in elderly persons and the lack of knowledge about true nutritional needs in wound healing. The consumption of a diet high in protein and energy may promote pressure ulcer healing. When considering nutritional support, oral supplementation should be weighted against tube feeding, as the associated morbidity of tube feeding, i.e., diarrhea, fecal incontinence, and restricted mobility being in themselves risk factors for pressure ulcers, might obscure the favorable effects of adequate nutrition. Despite the evidence in animal studies, none of the above-mentioned specific nutrients promoted the healing of pressure ulcers in humans. Therefore, the attention should be focused on early recognition of a depleted nutritional status and an adequate and supervised intake of energy (35 kcal/kg) and protein (1.5 g/kg) with provision of the recommended daily allowances of micronutrients and with correction of the nutrient deficiencies of old ag
Obesity and the Elderly
The prevalence of obesity is rising progressively, even among older age groups. By the year 2030 to 2035 over 20% of the adult US population and over 25% of the Europeans will be aged 65 years or older. The predicted prevalence of obesity in Americans, 60 years and older was 37% in 2010. The predicted prevalence of obesity in Europe in 2015 varies between 20% and 30% dependent on the model used. This means 20.9 million obese 60 years or older people in the United States in 2010 and 32 million obese elders in 2015 in EU. Although cutoff values of body mass index, waist circumference, and percentages of fat mass have not been defined for the elderly, it is clear from several meta-analyses that mortality and morbidity associated with overweight and obesity only increases at a body mass index > 30kg/m(2). Thus, treatment should only be offered to patients who are obese rather than overweight and who have functional impairments, metabolic complications, or obesity-related diseases, that can benefit from weight loss. The weight loss therapy should minimize muscle and bone loss and vigilance as regards the development of sarcopenic obesity-a combination of an unhealthy excess of body fat with a detrimental loss of muscle and fat-free mass including bone-is important. Lifestyle intervention should be the first step and consists of a diet with a 500 kcal energy deficit and an adequate intake of protein of high biological quality, together with calcium and vitamin D, behavioral therapy, and multicomponent exercise. Multicomponent exercise includes flexibility training, balance training, aerobic exercise, and resistance training. The adherence rate in most studies is around 75%. Knowledge of constraints and modulators of physical inactivity should be of help to engage the elderly in physical activity. The role of pharmacotherapy and bariatric surgery in the elderly is largely unknown as in most studies people aged 65 years and older were exclude
Is Endoscopy Really Necessary for Placing Intragastric Balloons?
Gastric balloons for weight loss have historically been placed after a screening endoscopy. However, the utility and yield of these endoscopies has not been studied. Therefore, we wanted to evaluate the utility of screening endoscopy and to assess patients who had balloons placed without endoscopy. Data was collected on two cohorts. Cohort 1 consisted of patients who had a screening endoscopy prior to or upon balloon placement. Cohort 2 consisted of patients who were followed after having a balloon placed under fluoroscopic guidance without endoscopy. Balloon intolerance and findings on removal endoscopy were assessed in both cohorts. In cohort 1 (n = 253), two patients had severe symptoms on history; balloon placement was contraindicated based on screening endoscopy findings. Eleven patients with a history of hiatal hernia and the presence of severe belching demonstrated an insignificant hiatal hernia on endoscopy. In cohort 2 (n = 50), all patients had an unremarkable history. Three previously asymptomatic patients had balloon intolerance and one was found to have a 4-cm hiatal hernia and oesophagitis upon balloon removal. Out of 194 patients, 25 were either intolerant to the balloon or had relevant findings on removal endoscopy. Findings on screening endoscopy did not correlate with balloon intolerance or findings on removal endoscopy. These results demonstrate that a careful history can identify patients who may have contraindications for balloon therapy and that balloons can be placed safely after taking a careful history without screening endoscopy. Screening endoscopy may not be useful in predicting balloon intolerance or potential complication
- …